This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $200,714.25 and has an ultimate completion date of August 26, 2024.
The contract is for the delivery of various pharmaceutical products to support the medical supply needs of the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities nationwide. The specific products include branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables such as flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, contraceptives, oncology drugs like Keytruda, and specialty medications.
This delivery order is issued under a larger indefinite delivery contract (IDC) with DLA, valued at up to $499,999,999, which allows the agency to place firm fixed-price orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The IDC covers a vast array of pharmaceutical products, from common medications to specialized drugs and medical supplies, and solidifies DMS Pharmaceutical Group's position as a crucial supplier in the federal pharmaceutical supply chain.
Generated 11/4/24, 11:12 AM